Direxion Daily Pharmaceutical & Medical Bull 3X ETF
PILL
2 hedge funds and large institutions have $849K invested in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
3% less capital invested
Capital invested by funds: $873K → $849K (-$24K)
18.69% less ownership
Funds ownership: 24.57% → 5.88% (-19%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$160K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$39.4K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $813K | +$160K | +8,178 | +22% |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $36K | +$39.4K | +2,020 | New |
|
PILL Hedge Fund Activity: Q2 2019 in Review
2 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) for Q2 2019, worth a combined $849K — down 2.7% from $873K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new PILL positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $160K.
- 2 institutional investors held Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) as of Q2 2019, up from 1 in Q1 2019.
- Funds reported $849K of Direxion Daily Pharmaceutical & Medical Bull 3X ETF stock for Q2 2019, down 2.7% quarter-over-quarter.
- 1 fund opened new Direxion Daily Pharmaceutical & Medical Bull 3X ETF positions in Q2 2019 and 0 closed out, a net change of +1 holder.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF buyer in Q2 2019 was Susquehanna International Group, an estimated $160K added.
Based on aggregated 13F filings for Q2 2019.